Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel.
Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel.
Injury. 2019 Jul;50(7):1347-1352. doi: 10.1016/j.injury.2019.05.022. Epub 2019 May 22.
With the aging of the population the rate of fragility hip fractures increases. While medical recommendations are for hasten surgical treatment, for some older patients burdened with severe comorbidities, this might be risky.
To compare the outcomes of patients treated non-surgically to those of the most fragile patients treated surgically.
A retrospective cohort study, of individuals aged ≥65 years who presented with fragility hip fractures between 01.01.2011-30.06.2016, to a primary trauma center. Patients treated surgically were stratified according to their age-adjusted Charlsons' comorbidity index (ACCI) score. Patients in the upper third of ACCI score, representing the more fragile population, were compared to patients treated non-surgically.
847 patients presented with fragility fractures. 94 (11%) were treated non-surgically and 753 (89%) underwent surgery. Medical reasons were the leading cause for non-surgical treatment (61.7%). Surgically-treated patients were stratified according to their ACCI and 114 patients with ACCI > 9 were chosen for comparison. While both groups were comparable in terms of age, the non-surgical treatment group had more female patients (p. = 0.026) and a smaller proportion of independent walkers (p < 0.001). The ACCI was higher for the surgical treatment group (p < 0.001). In-hospital mortality was similar (14.9% and 18.1% for the operative and non-surgical groups respectively, P. = 0.575). However, one-year mortality was significantly higher for the non-surgical group (48.2% vs. 67.0%, P. = 0.005). The rates of in-hospital complications and 1-year readmissions were similar.
Operative treatment for fragility hip fracture reduces long-term mortality rates even in the more fragile patients, compared to non-surgical treatment.
随着人口老龄化,脆性髋部骨折的发生率增加。虽然医学建议尽快进行手术治疗,但对于一些患有严重合并症的老年患者来说,这可能存在风险。
比较非手术治疗患者和最脆弱的手术治疗患者的结局。
这是一项回顾性队列研究,纳入了 2011 年 1 月 1 日至 2016 年 6 月 30 日期间在一家初级创伤中心就诊的年龄≥65 岁的脆性髋部骨折患者。根据年龄调整后的 Charlson 合并症指数(ACCI)评分对接受手术治疗的患者进行分层。在 ACCI 评分较高的上三分之一(代表更脆弱的人群)的患者与非手术治疗的患者进行比较。
共有 847 例患者发生脆性骨折。94 例(11%)接受非手术治疗,753 例(89%)接受手术治疗。非手术治疗的主要原因是医学原因(61.7%)。手术治疗的患者根据其 ACCI 进行分层,并选择 114 例 ACCI>9 的患者进行比较。虽然两组在年龄方面具有可比性,但非手术治疗组女性患者更多(p=0.026),独立行走者比例较小(p<0.001)。手术治疗组的 ACCI 更高(p<0.001)。住院死亡率相似(手术组和非手术组分别为 14.9%和 18.1%,P=0.575)。然而,非手术组的 1 年死亡率明显更高(48.2% vs. 67.0%,P=0.005)。住院并发症和 1 年再入院率相似。
与非手术治疗相比,手术治疗脆性髋部骨折可降低长期死亡率,即使是在更脆弱的患者中。